Recombinant multi-species IL-1F7/IL-37/IL37 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-1F7/IL-37/IL37 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine can bind to, and may be a ligand for interleukin 18 receptor (IL18R1/IL-1Rrp). This cytokine also binds to interleukin 18 binding protein (IL18BP), an inhibitory binding protein of interleukin 18 (IL18), and subsequently forms a complex with IL18 receptor beta subunit, and through which it inhibits the activity of IL18. This gene along with eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Five alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
The Alternative Names of target: IL-1F7, IL-37, IL37,Interleukin-37,IL-37,FIL1 zeta, IL-1X, Interleukin-1 family member 7 (IL-1F7), Interleukin-1 homolog 4 (IL-1H, IL-1H4), Interleukin-1 zeta (IL-1 zeta), Interleukin-1-related protein (IL-1RP1),FIL1,FIL1Z,IL-1H,IL-23,IL-37,IL1F7,IL1H4,IL-1F7,IL-1H4,IL1RP1,IL-1RP1,FIL1(ZETA)
Go
to IL-1F7/IL-37/IL37 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T96845-Ab-1/ GM-Tg-hg-T96845-Ab-2 | Human IL-1F7/IL-37/IL37 protein | Human |
GM-Tg-rg-T96845-Ab-1/ GM-Tg-rg-T96845-Ab-2 | Rat IL-1F7/IL-37/IL37 protein | Rat |
GM-Tg-mg-T96845-Ab-1/ GM-Tg-mg-T96845-Ab-2 | Mouse IL-1F7/IL-37/IL37 protein | Mouse |
GM-Tg-cynog-T96845-Ab-1/ GM-Tg-cynog-T96845-Ab-2 | Cynomolgus/Rhesus macaque IL-1F7/IL-37/IL37 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T96845-Ab-1/ GM-Tg-felg-T96845-Ab-2 | Feline IL-1F7/IL-37/IL37 protein | Feline |
GM-Tg-cang-T96845-Ab-1/ GM-Tg-cang-T96845-Ab-2 | Canine IL-1F7/IL-37/IL37 protein | Canine |
GM-Tg-bovg-T96845-Ab-1/ GM-Tg-bovg-T96845-Ab-2 | Bovine IL-1F7/IL-37/IL37 protein | Bovine |
GM-Tg-equg-T96845-Ab-1/ GM-Tg-equg-T96845-Ab-2 | Equine IL-1F7/IL-37/IL37 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T96845-Ab-1/ GM-Tg-hg-T96845-Ab-2;
GM-Tg-rg-T96845-Ab-1/ GM-Tg-rg-T96845-Ab-2;
GM-Tg-mg-T96845-Ab-1/ GM-Tg-mg-T96845-Ab-2; GM-Tg-cynog-T96845-Ab-1/ GM-Tg-cynog-T96845-Ab-2; GM-Tg-felg-T96845-Ab-1/ GM-Tg-felg-T96845-Ab-2; GM-Tg-cang-T96845-Ab-1/ GM-Tg-cang-T96845-Ab-2; GM-Tg-bovg-T96845-Ab-1/ GM-Tg-bovg-T96845-Ab-2; GM-Tg-equg-T96845-Ab-1/ GM-Tg-equg-T96845-Ab-2 |
Products Name | IL-1F7/IL-37/IL37 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | IL-1F7/IL-37/IL37 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-1F7/IL-37/IL37 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.